Cancer Biomarker Discovery: The Entropic Hallmark
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
BACKGROUND: It is a commonly accepted belief that cancer cells modify their transcriptional state during the progression of the disease. We propose that the progression of cancer cells towards malignant phenotypes can be efficiently tracked using high-throughput technologies that follow the gradual changes observed in the gene expression profiles by employing Shannon's mathematical theory of communication. Methods based on Information Theory can then quantify the divergence of cancer cells' transcriptional profiles from those of normally appearing cells of the originating tissues. The relevance of the proposed methods can be evaluated using microarray datasets available in the public domain but the method is in principle applicable to other high-throughput methods. METHODOLOGY/PRINCIPAL FINDINGS: Using melanoma and prostate cancer datasets we illustrate how it is possible to employ Shannon Entropy and the Jensen-Shannon divergence to trace the transcriptional changes progression of the disease. We establish how the variations of these two measures correlate with established biomarkers of cancer progression. The Information Theory measures allow us to identify novel biomarkers for both progressive and relatively more sudden transcriptional changes leading to malignant phenotypes. At the same time, the methodology was able to validate a large number of genes and processes that seem to be implicated in the progression of melanoma and prostate cancer. CONCLUSIONS/SIGNIFICANCE: We thus present a quantitative guiding rule, a new unifying hallmark of cancer: the cancer cell's transcriptome changes lead to measurable observed transitions of Normalized Shannon Entropy values (as measured by high-throughput technologies). At the same time, tumor cells increment their divergence from the normal tissue profile increasing their disorder via creation of states that we might not directly measure. This unifying hallmark allows, via the the Jensen-Shannon divergence, to identify the arrow of time of the processes from the gene expression profiles, and helps to map the phenotypical and molecular hallmarks of specific cancer subtypes. The deep mathematical basis of the approach allows us to suggest that this principle is, hopefully, of general applicability for other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Moser, J., Kool, H., Giakzidis, I., Caldecott, K., Mullenders, L. H. F., & Fousteri, M. I. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.014 · Cited by 261
RetractedTumor cell metabolism: cancer's Achilles' heel
Kroemer, G., & Pouyssegur, J. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.005 · Cited by 2,337 · cited 1×
“These authors cite, for example, ''mitochondrial dysfunction'' [5, 6] (including, but not limited to ''glucose avidity'' [7] and ''a shift in glucosemetabolism from oxidative phosphorylation to glycolysis'' [6, 8] , ''altered glycolysis'' [9] , ''altered bioenergetic function of mitochondria'' [10] ), ''dysregulation…”
Clemson, C. M., Hutchinson, J. N., Sara, S. A., Ensminger, A. W., Fox, A. H., Chess, A., & Lawrence, J. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.026 · Cited by 1,445 · cited 2×
“[754,760,762,764,778], that colocalizes with paraspeckles, seems”
Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment
Harlin, H., Meng, Y., Peterson, A. C., Zha, Y., Tretiakova, M., Slingluff, C., McKee, M., & Gajewski, T. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2281 · Cited by 1,121 · cited 4×
“Again using GATHER [155] on the first 44 genes recognized by the software, and again using Gene Ontology, we observe as most important common function that of cell motility (CCL3, CXCL10, FPRL1, SEMA6A, SPP1), p-value = 0.0002, Bayes Factor 5, and chemotaxis (CCL3, CKLFSF7, CXCL10, FPRL1, SPP1), p-value,0.0001, Bayes…”
BackgroundInfluentialA Statistical Measure of Complexity
López-Ruiz, R., Mancini, H. L., & Calbet, X. (1995) · Physics Letters A · doi:10.1016/0375-9601(95)00867-5 · Cited by 920
Chromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
MicroRNAs and Other Tiny Endogenous RNAs in C. elegans
Ambros, V., Lee, R. C., Lavanway, A., Williams, P. T., & Jewell, D. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00287-2 · Cited by 706
Pham, C. G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.10.017 · Cited by 663
Disruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612 · cited 1×
“[20,21], ‘‘aneuploidy’’ and ‘‘chromosome aberrations’’ [22,23,24,25,26], ‘‘disruption of cellular junctions’’ [27], ‘‘avoidance of the immune response’’ [28], ‘‘pre-existing chronic inflammatory conditions’’ [29,30], ‘‘cancerrelated inflammation’’ [29], ‘‘disabled autophagy’’ [28], ‘‘impaired cellular senescence’’ [31…”
Skin hydration: A review on its molecular mechanisms
Verdier‐Sévrain, S., & Bonté, F. (2007) · Journal of Cosmetic Dermatology · doi:10.1111/j.1473-2165.2007.00300.x · Cited by 605 · cited 1×
“This may indicate an impared function on skin hydration [184,185,716,717,718,719].”
BackgroundRoles of p53, MYC and HIF-1 in regulating glycolysis–the seventh hallmark of cancer
Yeung, S. J., Pan, J., & Lee, M.-H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8224-x · Cited by 514 · cited 1×
“These authors cite, for example, ‘‘mitochondrial dysfunction’’ [5,6] (including, but not limited to ‘‘glucose avidity’’ [7] and ‘‘a shift in glucosemetabolism from oxidative phosphorylation to glycolysis’’ [6,8], ‘‘altered glycolysis’’ [9], ‘‘altered bioenergetic function of mitochondria’’ [10]), ‘‘dysregulation of ce…”
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411
miR-203 represses ‘stemness’ by repressing ΔNp63
Lena, A. M., Shalom-Feuerstein, R., di Val Cervo, P. R., Aberdam, D., Knight, R. A., Melino, G., & Candi, E. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.69 · Cited by 389
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
Program, N. C. S., Prickett, T. D., Agrawal, N. S., Wei, X., Yates, K. E., Lin, J. C., Wunderlich, J. R., Cronin, J. C., Cruz, P., Rosenberg, S. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.438 · Cited by 352 · cited 2×
“associated protein 1) [254], BST2/Bone marrow stromal antigen 2/Tetherin [255], CCL3/MIP-1alpha [256,257,258], CCT4, CDCA5/Sororin [259,260,261,262,263], CENPF/Mitosin [264], CXCL1/chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) [265,266,267,268,269,270,271,272, 273,274,275,276,277,278,2…”
BackgroundGhosh, S., Spagnoli, G. C., Martin, I., Ploegert, S., Demougin, P., Heberer, M., & Reschner, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20320 · Cited by 326
Role of human noncoding RNAs in the control of tumorigenesis
Li, L., Feng, T., Lian, Y., Zhang, G., Garen, A., & Song, X. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906005106 · Cited by 185 · cited 1×
“The role of SFPQ/PSF in the control of tumorigenesis is under investigation [787] and the information coming from”
BackgroundJin, R. J., Lho, Y., Connelly, L., Wang, Y., Yu, X., Saint Jean, L., Case, T. C., Ellwood-Yen, K., Sawyers, C. L., Bhowmick, N. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0107 · Cited by 182
The pro‐apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1
Cinar, B., Fang, P., Lutchman, M., Di Vizio, D., Adam, R. M., Pavlova, N., Rubin, M. A., Yelick, P. C., & Freeman, M. R. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601872 · Cited by 136 · cited 1×
“report an inverse correlation between XBP1 expression and histological differentiation in a series of prostate cancers without hormonal therapy, the expression of XBP1 was localized in epithelial and adenocarcinoma cells of the prostate and the majority of refractory cancer cases exhibited weak XBP1 expression), MST1/…”
BackgroundThe nuclear lamina. Both a structural framework and a platform for genome organization
Bridger, J. M., Foeger, N., Kill, I. R., & Herrmann, H. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05694.x · Cited by 123
Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells
Gray, C. P., Arosio, P., & Hersey, P. (2002) · Blood · doi:10.1182/blood.v99.9.3326 · Cited by 118
Toward Theoretical Analyis of Long-Range Proton Transfer Kinetics in Biomolecular Pumps
König, P. H., Ghosh, N., Hoffmann, M., Elstner, M., Tajkhorshid, E., Frauenheim, T., & Cui, Q. (2006) · The Journal of Physical Chemistry A · doi:10.1021/jp052328q · Cited by 114 · cited 1×
“The elicitation of the detailed mechanistic explanation of this extraordinary selectivity is under intense investigation with a number of techniques, including sophisticated molecular dyanamics simulations, for an overview of this field see [665, 693, 694, 695, 696, 697, 698, 699, 700, 701, 702, 703, 704, 705, 706, 70…”
BackgroundPekovic, V., & Hutchison, C. J. (2008) · Journal of Anatomy · doi:10.1111/j.1469-7580.2008.00928.x · Cited by 75
Gray, C. P., Franco, A. V., Arosio, P., & Hersey, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1269 · Cited by 70 · cited 2×
“associated protein 1) [254], BST2/Bone marrow stromal antigen 2/Tetherin [255], CCL3/MIP-1alpha [256,257,258], CCT4, CDCA5/Sororin [259,260,261,262,263], CENPF/Mitosin [264], CXCL1/chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) [265,266,267,268,269,270,271,272, 273,274,275,276,277,278,2…”
BackgroundKaufmann, W. K., Nevis, K. R., Qu, P., Ibrahim, J. G., Zhou, T., Zhou, Y., Simpson, D. A., Helms-Deaton, J., Cordeiro-Stone, M., Moore, D. T., et al. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700935 · Cited by 65
Function of JunB in transient amplifying cell senescence and progression of human prostate cancer.
Konishi, N., Shimada, K., Nakamura, M., Ishida, E., Ota, I., Tanaka, N., & Fujimoto, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4120 · Cited by 46 · cited 2×
“003 (ATP6AP2, BCAT1, BTG2 [572,573,574,575,576,577,578], C14orf123, C18orf45, CCL2, CD302, CD40 (already discussed), CD59 (already discussed), CHI3L1, COL16A1, COMMD6, CRABP2, CSRP1, CTBP2, CTGF (Connective tissue growth factor, [579,580,581,582]), DES, DMN, DNAJB1, EGF, EMP1, FHL2 [583,584,585,586,587,588], GRIPAP1,…”
Influential
Cited by
Evolutionary Dynamics of Gene and Isoform Regulation in Mammalian Tissues
Merkin, J., Russell, C., Chen, P., & Burge, C. B. (2012) · Science · doi:10.1126/science.1228186 · Cited by 972
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
Milioli, H. H., Tishchenko, I., Riveros, C., Berretta, R., & Moscato, P. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0250-9 · Cited by 366
Self-citationBlood-informative transcripts define nine common axes of peripheral blood gene expression
Preininger, M., Arafat, D., Kim, J., Nath, A. P., Idaghdour, Y., Brigham, K. L., & Gibson, G. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003362 · Cited by 59
Single-cell systems analysis: decision geometry in outliers
Abrahams, L. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa1078 · Cited by 3
Metadata
- Authors
- Berretta, R., & Moscato, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-08-18
- Volume
- 5
- Issue
- 8
- Pages
- e12262
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1991549110
- Cited by
- 55
- References
- 25
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.